Scott William Drake View Ray, Inc. (VRAY) insider trading activity

Scott William Drake is Director of ViewRay, Inc.. Currently has a direct ownership of 1.59 Million shares of VRAY, which is worth approximately $15,916. The most recent transaction as insider was on Jul 18, 2023, when has been sold 2,408,747 shares (Common Stock) at a price of $0.06 per share, resulting in proceeds of $144,524. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.59M

0% 3M change

0% 12M change

Total Value Held $15,916

Scott William Drake Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 18 2023	SELL Open market or private sale	$144,524 $0.06 p/Share	2,408,747 Reduced 60.21%	1,591,615 Common Stock
Jun 15 2023	SELL Payment of exercise price or tax liability	$55,681 $0.48 p/Share	116,003 Reduced 2.82%	4,000,362 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$158,614 $4.25 p/Share	37,321 Reduced 0.9%	4,116,365 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$672,474 $4.34 p/Share	154,948 Reduced 3.6%	4,153,686 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	483,870 Added 10.1%	4,308,634 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$424,802 $4.4 p/Share	96,546 Reduced 2.46%	3,824,764 Common Stock
Oct 24 2022	SELL Payment of exercise price or tax liability	$307,973 $4.16 p/Share	74,032 Reduced 1.85%	3,921,310 Common Stock
Jun 15 2022	SELL Payment of exercise price or tax liability	$313,116 $2.69 p/Share	116,400 Reduced 2.83%	3,995,342 Common Stock
May 11 2022	BUY Open market or private purchase	$296,040 $2.53 p/Share	117,012 Added 2.77%	4,111,742 Common Stock
May 10 2022	BUY Open market or private purchase	$104,400 $2.61 p/Share	40,000 Added 0.99%	3,994,730 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$158,784 $4.24 p/Share	37,449 Reduced 0.94%	3,954,730 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$460,099 $4.14 p/Share	111,135 Reduced 3.07%	3,509,088 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	483,091 Added 10.79%	3,992,179 Common Stock
Jan 02 2022	SELL Payment of exercise price or tax liability	$529,280 $5.51 p/Share	96,058 Reduced 2.58%	3,620,223 Common Stock
Nov 19 2021	BUY Open market or private purchase	$499,996 $5.6 p/Share	89,285 Added 2.35%	3,716,281 Common Stock
Oct 24 2021	SELL Payment of exercise price or tax liability	$504,158 $6.81 p/Share	74,032 Reduced 2.0%	3,626,996 Common Stock
Jul 22 2021	SELL Payment of exercise price or tax liability	$1,103,675 $6.53 p/Share	169,016 Reduced 4.37%	3,701,028 Common Stock
Jun 15 2021	SELL Payment of exercise price or tax liability	$982,821 $5.83 p/Share	168,580 Reduced 4.17%	3,870,044 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$168,895 $4.51 p/Share	37,449 Reduced 0.92%	4,038,624 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$122,777 $4.66 p/Share	26,347 Reduced 0.75%	3,496,674 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	579,399 Added 12.45%	4,076,073 Common Stock
Nov 10 2020	BUY Open market or private purchase	$500,650 $3.23 p/Share	155,000 Added 4.06%	3,662,310 Common Stock
Oct 24 2020	SELL Payment of exercise price or tax liability	$226,209 $3.05 p/Share	74,167 Reduced 2.07%	3,507,310 Common Stock
Jan 02 2020	SELL Payment of exercise price or tax liability	$532,084 $3.82 p/Share	139,289 Reduced 3.8%	3,523,021 Common Stock

Also insider at

ATRC

AtriCure, Inc. Healthcare

Director

FNA

Paragon 28, Inc. Healthcare

Director

SWD